{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:31:29Z","timestamp":1794479489557,"version":"4.9.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014052","name":"UCL Queen Square Institute of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021730","name":"Alberta Prion Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007114","name":"African Institute for Mathematical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022596","name":"Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurobiolaging.2026.04.009","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:59:54Z","timestamp":1777647594000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Disentangling amyloid polymorphs in normal aging and Alzheimer's disease using dual-probe spectral imaging"],"prefix":"10.1016","volume":"165","author":[{"given":"Anastasiia A.","family":"Stepanchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Stys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib1","first-page":"552","article-title":"Insights into prion strains and neurotoxicity","volume":"8","author":"Aguzzi","year":"2007"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib3","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.9b00404","article-title":"Interrogating amyloid aggregates using fluorescent probes","author":"Aliyan","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","article-title":"Posttranslational modifications mediate the structural diversity of tauopathy strains","volume":"180","author":"Arakhamia","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-3940(94)90289-5","article-title":"\u03b2-Amyloid (A\u03b2) deposition in elderly non-demented patients and patients with Alzheimer\u2019s disease","volume":"178","author":"Armstrong","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/neur.1996.0005","article-title":"A comparison of \u03b2-amyloid deposition in the medial temporal lobe in sporadic Alzheimer\u2019s disease, Down\u2019s syndrome and normal elderly brains","volume":"5","author":"Armstrong","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113489119","article-title":"Different \u03b1-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy","volume":"119","author":"Ayers","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib8","first-page":"203","article-title":"Amyloid-beta immunotherapy: the hope for Alzheimer disease?","volume":"47","author":"Barrera-Ocampo","year":"2016","journal-title":"Colomb. M\u00e9dica CM"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3233\/JAD-215402","article-title":"Diagnosing Alzheimer\u2019s disease from circulating blood leukocytes using a fluorescent amyloid probe","volume":"85","author":"Black","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01117-1","article-title":"The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer\u2019s disease: a literature review","volume":"14","author":"Brand","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib12","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1038\/s41598-018-25131-2","article-title":"Solvation-guided design of fluorescent probes for discrimination of amyloids","volume":"8","author":"Cao","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib13","series-title":"Translational opportunities for amyloid-targeting fluorophores","first-page":"9107","author":"Cao","year":"2018"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005551","article-title":"Prion strain differences in accumulation of PrPSc on neurons and glia are associated with similar expression profiles of neuroinflammatory genes: comparison of three prion strains","volume":"12","author":"Carroll","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib15","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/19336896.2015.1123371","article-title":"Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer\u2019s disease","volume":"10","author":"Cohen","year":"2016","journal-title":"Prion"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","article-title":"Rapidly progressive Alzheimer\u2019s disease features distinct structures of amyloid-\u03b2","volume":"138","author":"Cohen","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib18","doi-asserted-by":"crossref","first-page":"E782","DOI":"10.1073\/pnas.1714966115","article-title":"Structural heterogeneity and intersubject variability of A\u03b2 in familial and sporadic Alzheimer\u2019s disease","volume":"115","author":"Condello","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2212954119","article-title":"A\u03b2 and tau prions feature in the neuropathogenesis of Down syndrome","volume":"119","author":"Condello","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2017.03.014","article-title":"A\u03b2 propagation and strains: Implications for the phenotypic diversity in Alzheimer\u2019s disease","volume":"109","author":"Condello","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2021.110074","article-title":"Benzothiazole based fluorescent probes for the detection of biomolecules, physiological conditions, and ions responsible for diseases","volume":"199","author":"Das","year":"2022","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib22","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cne.24080","article-title":"Comprehensive cellular-resolution atlas of the adult human brain","volume":"524","author":"Ding","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jnen\/nlac066","article-title":"Differential vulnerability of hippocampal subfields in primary age-related tauopathy and chronic traumatic encephalopathy","volume":"81","author":"Farrell","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2026.04.009_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41594-024-01252-3","article-title":"Cryo-EM structures of amyloid-\u03b2 and tau filaments in Down syndrome","volume":"31","author":"Fernandez","year":"2024","journal-title":"Nat. Struct. Mol. Biol. 2024"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","article-title":"Biological subtypes of Alzheimer disease: a systematic review and meta-analysis","volume":"94","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/10409238.2016.1226251","article-title":"Potential mechanisms and implications for the formation of tau oligomeric strains","volume":"51","author":"Gerson","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib27","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","article-title":"Longitudinal \u03b2-amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non\u2013Alzheimer disease pathophysiology","volume":"73","author":"Gordon","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2008.07.006","article-title":"Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent","volume":"379","author":"Greil","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib29","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"In vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib31","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/JVI.03082-12","article-title":"Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type","volume":"87","author":"Hannaoui","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","article-title":"Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer Disease","volume":"55","author":"Haroutunian","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","article-title":"Concurrence of TDP-43, tau and \u03b1-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"1184","author":"Higashi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib36","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.medj.2024.08.004","article-title":"Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer\u2019s disease","volume":"5","author":"Hu","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib37","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00401-022-02500-w","article-title":"Expanding the spectrum of amyloid-\u03b2 plaque pathology: the Down syndrome associated \u2018bird-nest plaque","volume":"144","author":"Ichimata","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.58.5.750","article-title":"Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia","volume":"58","author":"Jack","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib40","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1002\/chem.201301463","article-title":"The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: Conformational flexibility is essential for spectral assignment of a diversity of protein aggregates","volume":"19","author":"Klingstedt","year":"2013","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib41","article-title":"Dual-ligand fluorescence microscopy enables chronological and spatial histological assignment of distinct amyloid-\u03b2 deposits","volume":"301","author":"Klingstedt","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202203568","article-title":"Thiophene-based ligands for histological multiplex spectral detection of distinct protein aggregates in Alzheimer\u2019s disease","author":"Lantz","year":"2023","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib44","article-title":"The existence of A\u03b2 strains and their potential for driving phenotypic heterogeneity in Alzheimer\u2019s disease","author":"Lau","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"\u03b1-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib46","article-title":"Structures of brain-derived 42-residue amyloid-\u03b2 fibril polymorphs with unusual molecular conformations and intermolecular interactions","volume":"120","author":"Lee","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2026.04.009_bib47","first-page":"1","article-title":"The in-tissue molecular architecture of \u03b2-amyloid pathology in the mammalian brain","volume":"14","author":"Leistner","year":"2023","journal-title":"Nat. Commun. 2023"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib48","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1183218","article-title":"Darwinian evolution of prions in cell culture","volume":"327","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41583-022-00603-7","article-title":"Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101267","article-title":"Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer\u2019s disease","volume":"297","author":"Liu","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45429-2","article-title":"Local structural preferences in shaping tau amyloid polymorphism","volume":"15","author":"Louros","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib52","article-title":"Atlas of the Human Brain. 3rd Edition","author":"Mai","year":"2011","journal-title":"J. Phys. A Math. Theor."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003759","article-title":"The evolution of transmissible prions: the role of deformed templating","volume":"9","author":"Makarava","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01298-0","article-title":"Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer\u2019s disease pathology in Down syndrome","volume":"9","author":"Maxwell","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib55","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research","author":"Moloney","year":"2021","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib56","article-title":"The neurofibrillary tangle maturity scale: a novel framework for tangle pathology evaluation in Alzheimer's disease","author":"Moloney","year":"2025","journal-title":"bioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib57","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hbm.20934","article-title":"Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer\u2019s disease","volume":"31","author":"Mueller","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib59","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/cb4000376","article-title":"Evidence for age-dependent in vivo conformational rearrangement within A\u03b2 amyloid deposits","volume":"8","author":"Nystr\u00f6m","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib61","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/acschemneuro.4c00104","article-title":"Divergent age-dependent conformational rearrangement within A\u03b2 amyloid deposits in APP23, APPPS1, and AppNL-F Mice","volume":"15","author":"Parvin","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","article-title":"\u0251-Synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences","volume":"373","author":"Peelaerts","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","article-title":"Distinct \u03b1-Synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies","volume":"109","author":"Peng","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0896-6273(02)00726-2","article-title":"A change in the conformation of prions accompanies the emergence of a new prion strain","volume":"34","author":"Peretz","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0729","article-title":"Association of variation in behavioral symptoms with initial cognitive phenotype in adults with dementia confirmed by neuropathology","volume":"5","author":"Pillai","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib66","doi-asserted-by":"crossref","first-page":"13018","DOI":"10.1073\/pnas.1713215114","article-title":"Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer\u2019s disease","volume":"114","author":"Rasmussen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1747-0285.2011.01110.x","article-title":"Insight into amyloid structure using chemical probes","volume":"77","author":"Reinke","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib68","article-title":"Alzheimer\u2019s disease and the amyloid cascade hypothesis: a critical review","volume":"2012","author":"Reitz","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11065-009-9118-x","article-title":"Beta-amyloid deposition and the aging brain","volume":"19","author":"Rodrigue","year":"2009","journal-title":"Neuropsychol. Rev."},{"issue":"Pt 11","key":"10.1016\/j.neurobiolaging.2026.04.009_bib70","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/0022-1317-73-11-3027","article-title":"Demonstration of scrapie strain diversity in infected PC12 cells","volume":"73","author":"Rubenstein","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib71","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","article-title":"Eight prion strains have PrP(Sc) molecules with different conformations","volume":"4","author":"Safar","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib72","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1192\/bjo.2023.227","article-title":"TRAILBLAZER-ALZ 4: Topline study results directly comparing donanemab to aducanumab on amyloid lowering in early, symptomatic Alzheimer\u2019s disease","volume":"9","author":"Salloway","year":"2023","journal-title":"BJPsych Open"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib73","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"issue":"7980","key":"10.1016\/j.neurobiolaging.2026.04.009_bib74","first-page":"701","article-title":"Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids","volume":"621","author":"Scheres","year":"2023","journal-title":"Nature 2023"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib76","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37813","article-title":"Tau monomer encodes strains","volume":"7","author":"Sharma","year":"2018","journal-title":"Elife"},{"issue":"7880","key":"10.1016\/j.neurobiolaging.2026.04.009_bib77","first-page":"359","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature 2021"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib78","doi-asserted-by":"crossref","first-page":"12537","DOI":"10.1002\/chem.201402890","article-title":"Pentameric thiophene-based ligands that spectrally discriminate amyloid-\u03b2 and tau aggregates display distinct solvatochromism and viscosity-induced spectral shifts","volume":"20","author":"Simon","year":"2014","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4161\/pri.23490","article-title":"A closer look at prion strains: characterization and important implications","volume":"7","author":"Solforosi","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib82","first-page":"1","article-title":"Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer\u2019s amyloid pathology","author":"Stepanchuk","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib83","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acschemneuro.3c00798","article-title":"Spectral fluorescence pathology of protein misfolding disorders","volume":"15","author":"Stepanchuk","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-021-02301-7","article-title":"Tau strains shape disease","volume":"142","author":"Vaquer-Alicea","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib86","doi-asserted-by":"crossref","unstructured":"Walker, L.C., 2016. Proteopathic strains and the heterogeneity of neurodegenerative diseases. https:\/\/doi.org\/10.1146\/annurev-genet-120215-034943.","DOI":"10.1146\/annurev-genet-120215-034943"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib87","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","article-title":"Neuroimaging correlates of pathologically defined subtypes of Alzheimer\u2019s disease: a case-control study","volume":"11","author":"Whitwell","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib88","first-page":"189","article-title":"Trajectories of CSF and plasma biomarkers across Alzheimer\u2019s disease continuum: disease staging by NF-L, p-tau181, and GFAP","author":"Wojda\u0142a","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib89","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"vivo imaging of amyloid deposition in Alzheimer disease using the radioligand F-AV-45 (Flobetapir F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.617173","article-title":"Exploring the pattern associated with longitudinal changes of \u03b2-amyloid deposition during cognitively normal healthy aging","volume":"7","author":"Xie","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.abm7285","article-title":"Cryo-EM structures of amyloid-\u03b2 42 filaments from human brain","volume":"375","author":"Yang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2026.04.009_bib92","article-title":"EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains","volume":"120","author":"Yang","year":"2023","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:06:14Z","timestamp":1794477974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":92,"alternative-id":["S0197458026000667"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.009","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disentangling amyloid polymorphs in normal aging and Alzheimer's disease using dual-probe spectral imaging","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}